Riverpoint Wealth Management Holdings’s AbbVie ABBV Stock Holding History

Riverpoint Wealth Management Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19M	Buy	8,709 +70	+0.8%	+$15.1K	0.4%	22
2026 Q1	$1.88M	Sell	8,639 -23	-0.3%	-$5.1K	0.4%	24
2025 Q4	$1.98M	Buy	8,662 +60	+0.7%	+$13.7K	0.43%	22
2025 Q3	$1.99M	Buy	8,602 +25	+0.3%	+$5.09K	0.44%	23
2025 Q2	$1.59M	Buy	8,577 +78	+0.9%	+$14.5K	0.37%	23
2025 Q1	$1.78M	Buy	8,499 +243	+3%	+$47.2K	0.46%	21
2024 Q4	$1.47M	Buy	8,256 +75	+0.9%	+$13.8K	0.38%	25
2024 Q3	$1.62M	Buy	8,181 +65	+0.8%	+$12.1K	0.41%	24
2024 Q2	$1.39M	Buy	8,116 +77	+1%	+$12.8K	0.39%	26
2024 Q1	$1.46M	Buy	8,039 +71	+0.9%	+$12.2K	0.41%	24
2023 Q4	$1.23M	Buy	7,968 +84	+1%	+$12.2K	0.36%	25
2023 Q3	$1.18M	Buy	7,884 +59	+0.8%	+$8.66K	0.39%	23
2023 Q2	$1.05M	Buy	7,825 +60	+0.8%	+$8.8K	0.33%	23
2023 Q1	$1.24M	Buy	7,765 +58	+0.8%	+$8.87K	0.43%	21
2022 Q4	$1.25M	Buy	7,707 +53	+0.7%	+$8.13K	0.46%	21
2022 Q3	$1.03M	Buy	7,654 +57	+0.8%	+$8.18K	0.44%	21
2022 Q2	$1.16M	Buy	7,597 +52	+0.7%	+$7.95K	0.47%	19
2022 Q1	$1.22M	Buy	7,545 +55	+0.7%	+$7.99K	0.42%	21
2021 Q4	$1.01M	Buy	7,490 +57	+0.8%	+$6.73K	0.34%	21
2021 Q3	$802K	Buy	7,433 +59	+0.8%	+$6.74K	0.28%	26
2021 Q2	$831K	Buy	7,374 +60	+0.8%	+$6.76K	0.23%	41
2021 Q1	$791K	Buy	7,314 +65	+0.9%	+$6.95K	0.24%	41
2020 Q4	$777K	Buy	7,249 +61	+0.8%	+$5.86K	0.25%	41
2020 Q3	$630K	Buy	7,188 +263	+4%	+$24.8K	0.23%	44
2020 Q2	$680K	Buy	+6,925	New	+$610K	0.27%	40

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Riverpoint Wealth Management Holdings's ABBV Position: Q2 2026 in Review

Riverpoint Wealth Management Holdings increased its AbbVie (ABBV) stake by 0.81% in Q2 2026, buying an estimated $15.1K and bringing the position to 8,709 shares worth $2.19M. The position accounts for 0.4% of the portfolio, ranked #22.

Riverpoint Wealth Management Holdings first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Riverpoint Wealth Management Holdings held 8,709 shares of AbbVie worth $2.19M as of Q2 2026.
Riverpoint Wealth Management Holdings bought 70 AbbVie shares in Q2 2026, an estimated $15.1K.
AbbVie made up 0.4% of Riverpoint Wealth Management Holdings's portfolio in Q2 2026, its #22 holding.
Riverpoint Wealth Management Holdings first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Riverpoint Wealth Management Holdings's 13F filing for Q2 2026, filed 27 Jul 2026.